Vertex Pharmaceuticals Incorporated vs Western Union Co — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.09 (market cap $121.95B), while Western Union Co trades at $8.9 (market cap $2.71B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 45× Western Union Co's market cap, and Western Union Co pays a 10.85% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | WU | |
|---|---|---|
Market Cap | $121.95B | $2.71B |
Sector | Health | Technology |
52-Week High | $529.59 | $10.28 |
52-Week Low | $366.54 | $7.04 |
Enterprise Value | $116.69B | $2.40B |
Dividend Yield | — | 10.85% |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →